Inferring the MoA of drugs based on barcode fingerprints

Author

Bastien CHASSAGNOL and Vera PANCALDI and Luca GRUMULATO and Marie-Pier SCOTT KELLY

Published

6 May 2025

Welcome

Star this website on Github

This is the online Quarto book project for reproducing: Inferring the mechanism of action of new drugs through the analysis of the predetermined heterogeneous response to treatment of different subpopulations of cancer cells poster, presented at NetBioMed 2022 conference.

Introduction: Cell lines DNA Barcoding

  • DNA barcoding is also used for inferring the species abundancies in environement samples, just replace the notion of species by cell lines. Similar statistical issues, with zero-inflated distributions.

  • Steps:

    1. Transfection by virus.
    2. Clonal amplification, unique tagging per cell using MOI.
    3. Clone sizes are assumed to be proportional to the barcode abundances due to this 1-1 mapping of a barcode and a single cell.
  • Pros DNA barcoding:

    • Better capture of cell population sizes
    • Better tracking of tagged clones.
  • Cons DNA barcoding:

    • Lack of systematic reviews and benchmarks.
    • Mostly rely on bulk RNASeq analytical tools, not accounting for drop-outs. In particular, the assumptions that variance across tags is homogeneous, and abundancies follow a negative binomial distribution are quite controversial.